Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient.

Seetharam AB, Borg BB, Subramanian V, Chapman WC, Crippin JS, Mohanakumar T.

Transplantation. 2011 Dec 27;92(12):1364-70. doi: 10.1097/TP.0b013e31823817f5.

2.

Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD.

Transplantation. 2011 Dec 15;92(11):1259-68. doi: 10.1097/TP.0b013e318235a1ab.

3.

Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.

Yue M, Deng X, Zhai X, Xu K, Kong J, Zhang J, Zhou Z, Yu X, Xu X, Liu Y, Zhu D, Zhang Y.

Immunol Lett. 2013 May;152(2):89-95. doi: 10.1016/j.imlet.2013.05.002. Epub 2013 May 13.

PMID:
23680070
4.

Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.

Tsuzaki R, Takaki A, Yagi T, Ikeda F, Koike K, Iwasaki Y, Shiraha H, Miyake Y, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Nobuoka D, Utsumi M, Nakayama E, Fujiwara T, Yamamoto K.

Acta Med Okayama. 2014;68(5):291-302.

5.

Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.

Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T.

Am J Transplant. 2011 Apr;11(4):775-85. doi: 10.1111/j.1600-6143.2011.03458.x.

6.

Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation.

Utsumi M, Takaki A, Umeda Y, Koike K, Napier SC, Watanabe N, Sadamori H, Shinoura S, Yoshida R, Nobuoka D, Yasunaka T, Nakayama E, Yamamoto K, Fujiwara T, Yagi T.

Transpl Immunol. 2014 Jun;31(1):33-41. doi: 10.1016/j.trim.2014.05.006. Epub 2014 Jun 5.

PMID:
24907425
7.

Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.

Gao Y, Ren H, Meng F, Li J, Cheung E, Li H, Zhao J, Liu H, Liu Z, Zhang M.

PLoS One. 2016 Apr 28;11(4):e0154419. doi: 10.1371/journal.pone.0154419. eCollection 2016.

8.

Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.

Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH.

Liver Transpl Surg. 1995 Nov;1(6):354-7.

9.

Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.

Bizollon T, Ahmed SN, Guichard S, Chevallier P, Adham M, Ducerf C, Baulieux J, Trepo C.

Gut. 2000 Nov;47(5):698-702.

10.

Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.

Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA; ATAHC Study Group..

J Viral Hepat. 2011 Aug;18(8):549-61. doi: 10.1111/j.1365-2893.2010.01335.x. Epub 2010 Jul 5.

11.

Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.

Hao C, Zhou Y, He Y, Fan C, Sun L, Wei X, Wang L, Peng M, Wang P, Lian J, Jia Z.

Immunology. 2014 Dec;143(4):531-8. doi: 10.1111/imm.12330.

12.

Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.

Sousa GM, Oliveira IS, Andrade LJ, Sousa-Atta ML, Paraná R, Atta AM.

Cytokine. 2012 Oct;60(1):138-42. doi: 10.1016/j.cyto.2012.06.003. Epub 2012 Jun 27.

13.

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.

Liver Transpl. 2004 Feb;10(2):199-207.

14.

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.

Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E.

Cytokine. 2004 Jul 7;27(1):7-14.

PMID:
15207246
15.

Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.

Raziorrouh B, Ulsenheimer A, Schraut W, Heeg M, Kurktschiev P, Zachoval R, Jung MC, Thimme R, Neumann-Haefelin C, Horster S, Wächtler M, Spannagl M, Haas J, Diepolder HM, Grüner NH.

Gastroenterology. 2011 Oct;141(4):1422-31, 1431.e1-6. doi: 10.1053/j.gastro.2011.07.004. Epub 2011 Jul 18.

PMID:
21763239
16.

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, Hoffmann R, Schirren CA, Santantonio T, Pape GR.

Gastroenterology. 1999 Oct;117(4):933-41.

PMID:
10500077
17.

Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation.

Thomas RM, Brems JJ, Guzman-Hartman G, Yong S, Cavaliere P, Van Thiel DH.

Liver Transpl. 2003 Sep;9(9):905-15.

18.

Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.

Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.

Liver Transpl. 2000 Mar;6(2):222-8.

PMID:
10719024
19.

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination.

Schirren CA, Zachoval R, Gerlach JT, Ulsenheimer A, Gruener NH, Diepolder HM, Baretton G, Schraut W, Rau HG, Nitschko H, Pape GR, Jung MC.

J Hepatol. 2003 Sep;39(3):397-404.

PMID:
12927926

Supplemental Content

Support Center